Physician profile
William A Hanner
NPI 1528386984
$2,110.44
in general payments reported to CMS, 2019-2025
14 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $186 · 2021: $61.06 · 2022: $61.40 · 2023: $180 · 2024: $1,382 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,042 · Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,041.52 |
| Food and Beverage | $760.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $1,201.79 | 2024 | Phasix Mesh |
| Organogenesis INC. | $262.91 | 2023-2025 | Novachor, Affinity, Apligraf |
| Medtronic, INC. | $166.67 | 2025 | Transorb |
| Tela Bio, INC. | $137.18 | 2020 | |
| Davol INC. | $83.00 | 2023 | Phasix Mesh |
| Allergan, INC. | $61.11 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $52.40 | 2022-2023 | Seglentis |
| Paratek Pharmaceuticals, INC. | $28.13 | 2023-2024 | Nuzyra |
| Stryker Corporation | $25.00 | 2021 | |
| Intuitive Surgical, INC. | $22.54 | 2023 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $20.93 | 2021 | |
| Integra Lifesciences Corporation | $20.64 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.13 | 2021 | |
| Zyla Life Sciences, INC. | $13.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.